Quercetin hydrogel

Where the papers sit

10 papers from the last 6 months study quercetin hydrogel directly · updated from PubMed 10 Oct 2026

• Quercetin Therapeutic Research

  Quercetin research here spans oral biofilms, reproductive toxicity, osteoarthritis, atherosclerosis and cancer. Localized sustained delivery is emphasized in the chlorhexidine-loaded PLGA nanoparticle study, while other work examines systemic metabolites or cellular senescence. Reported endpoints range from antimicrobial activity and sperm quality to chondrocyte aging and disease-associated macrophage states. The topics share the compound more than a biological question, so no common direction is established.

  5 papers · 50%

• Cancer Growth Signaling

  Quercetin is being investigated as a regulator of growth signaling in hepatocellular and gastric cancer. The recurring mechanisms involve EGFR and IGF1 pathways, with STAT3 and ESR1 appearing in broader network-based analyses. Molecular docking, network pharmacology and cell assays are being used to connect these signals with reduced proliferation or tumor progression. Evidence remains predominantly mechanistic and preclinical, with pathway-specific anticancer effects still requiring validation.

  3 papers · 30%

• Nanocarrier Cancer Apoptosis

  Combination nanocarriers are being developed to drive apoptosis in breast and colorectal cancer cells. One strategy co-delivers paclitaxel and quercetin through integrin αvβ3-targeted solid lipid nanoparticles, while another uses a quercetin-loaded orange-oil nanoemulsion. Apoptotic signaling and reduced cancer-cell viability are the shared endpoints. The work is moving toward localized combination delivery, but evidence remains limited to early cell-line studies.

  2 papers · 20%